Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development
Clin Pharmacol Ther
.
1992 Apr;51(4):465-73.
doi: 10.1038/clpt.1992.47.
Authors
C C Peck
1
,
W H Barr
,
L Z Benet
,
J Collins
,
R E Desjardins
,
D E Furst
,
J G Harter
,
G Levy
,
T Ludden
,
J H Rodman
, et al.
Affiliation
1
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20857.
PMID:
1563216
DOI:
10.1038/clpt.1992.47
No abstract available
Publication types
Congress
MeSH terms
Animals
Drug Evaluation / methods*
Drugs, Investigational* / pharmacokinetics
Drugs, Investigational* / pharmacology
Drugs, Investigational* / toxicity
Humans
Substances
Drugs, Investigational